Cyphos Injection 200 mg/vial contains Cyclophosphamide, a powerful cytotoxic and immunosuppressive agent widely used in the management of various cancers and autoimmune diseases. Cyclophosphamide is an alkylating agent that interferes with DNA replication and cellular proliferation, making it highly effective against rapidly dividing cells such as cancer cells.

Cyphos Injection 200 mg is formulated for intravenous administration in hospital or clinical settings under the supervision of trained healthcare professionals. It is frequently used in lower doses as part of combination chemotherapy regimens, maintenance therapy, or for the treatment of autoimmune disorders such as lupus and severe rheumatoid arthritis.

This formulation provides flexibility in dosing, allowing precise adjustment according to patient body surface area, age, and treatment requirements, making it suitable for both initial and maintenance therapy in various conditions.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Cyclophosphamide is a prodrug that is metabolized in the liver to active metabolites capable of cross-linking DNA strands. These cross-links prevent DNA replication and transcription, ultimately leading to cell death. Rapidly dividing cells, such as malignant tumor cells or activated immune cells, are most susceptible, which makes Cyclophosphamide effective in oncology and immunosuppression.

In autoimmune disorders, Cyclophosphamide suppresses abnormal immune activity by reducing the proliferation of B and T lymphocytes. This dual action helps control disease progression, reduce inflammation, and prevent organ damage associated with autoimmune conditions.

Indications

Cyphos Injection 200 mg/vial is indicated for:

• Various cancers including:

  • Non-Hodgkin’s lymphoma

  • Hodgkin’s disease

  • Leukemia

  • Breast and ovarian cancer

• Autoimmune disorders such as:

  • Systemic lupus erythematosus (SLE)

  • Severe rheumatoid arthritis

  • Vasculitis

• Conditioning therapy before bone marrow transplantation

The lower 200 mg vial is often preferred for dose titration, pediatric dosing, or as part of combination therapy requiring smaller individual doses.

Dosage and Administration

The dose of Cyphos Injection 200 mg depends on the patient’s condition, body surface area, and treatment protocol. It is administered intravenously, typically diluted in a suitable infusion fluid.

Healthcare providers closely monitor patients during administration and regularly check blood counts, liver and kidney function to ensure safety. Dosage schedules may vary based on whether the therapy is used for cancer treatment or immunosuppression.

Precautions and Warnings

• Use only under medical supervision in a hospital or clinic.

• Inform the physician if the patient has liver or kidney impairment, infections, or other chronic conditions.

• Pregnant or breastfeeding women should avoid exposure due to potential fetal or neonatal toxicity.

• Protective handling is necessary for healthcare providers, as Cyclophosphamide is cytotoxic.

• Regular monitoring is essential to prevent severe bone marrow suppression and infections.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

• Nausea and vomiting

• Hair loss (alopecia)

• Bone marrow suppression leading to low white blood cells, red blood cells, and platelets

• Increased susceptibility to infections

• Hemorrhagic cystitis (bladder irritation)

• Fatigue and weakness

• Rarely, long-term use may increase the risk of secondary cancers

Supportive therapies such as hydration, antiemetics, and monitoring can help manage side effects.

Storage Instructions

Store in a cool, dry place protected from light. Keep out of reach of children. Reconstituted solutions should be prepared and administered immediately according to clinical guidelines.

Cyphos Injection 200 mg/vial offers precise dosing and effective cytotoxic and immunosuppressive therapy, making it a versatile option in cancer care and the management of autoimmune diseases.